our results prove that ccsgu using the device system glucon induces a shift in substrate utilization from nefa to glucose , decreases myocardial oxygen extraction , increases myocardial glycogen content , enlarges heart work and protects against strophantin induced ventricular fibrillation .
C0027061
myocardial
C0018787
heart